miércoles, 3 de julio de 2019

Pfizer, Sarepta, and gene therapy: A race for a better Duchenne treatment

Pfizer, Sarepta, and gene therapy: A race for a better Duchenne treatment

Daily Recap

STAT Plus: The race for a better Duchenne treatment: Adam and Matt talk Pfizer, Sarepta, and gene therapy

By ADAM FEUERSTEIN AND MATTHEW HERPER


ADOBE
STAT's Matthew Herper and Adam Feuerstein sat down with some highly caffeinated beverages to look at the latest data and what they mean.

No hay comentarios: